Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-734741
Filing Date
2016-10-11
Accepted
2016-10-11 07:09:02
Documents
6
Effectiveness Date
2016-10-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d256232ddefa14a.htm DEFA14A 39557
2 GRAPHIC g2562322.jpg GRAPHIC 913
3 GRAPHIC g2562323.jpg GRAPHIC 924
4 GRAPHIC g2562324.jpg GRAPHIC 915
5 GRAPHIC g2562325.jpg GRAPHIC 916
6 GRAPHIC g256232page137a.jpg GRAPHIC 33568
  Complete submission text file 0001193125-16-734741.txt   92368
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 161929346
SIC: 2835 In Vitro & In Vivo Diagnostic Substances